Hepatitis C pp 403-413

Part of the Methods in Molecular Biology™ book series (MIMB, volume 510)

Determination of HCV-Specific T-Cell Activity

  • Joo Chun Yoon
  • Barbara Rehermann


The magnitude and breadth of T-cell responses against HCV are associated with the outcome of HCV infection. Parameters of HCV-specific T-cell responses that are frequently assessed in clinical immunological studies include proliferation of T cells in response to HCV antigens, frequency of HCV-specific T cells secreting cytokines, and changes in antigen specificity during the course of HCV infection. Common techniques for assessing these parameters such as 3H-thymidine incorporation assay, cytokine ELISpot assay, and strategies for epitope mapping and identification of minimal optimal epitopes are outlined, and detailed protocols are described.

Key Words

Hepatitis C virus T cell proliferation assay ELISpot assay epitope mapping 


  1. 1.
    Hoofnagle, J. H. (2002) Course and outcome of hepatitis C. Hepatology 36, S21–S29.CrossRefPubMedGoogle Scholar
  2. 2.
    Rehermann, B. and Nascimbeni, M. (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5, 215–229.CrossRefPubMedGoogle Scholar
  3. 3.
    Chisari, F. V. (2005) Unscrambling hepatitis C virus-host interactions. Nature 436, 930–932.CrossRefPubMedGoogle Scholar
  4. 4.
    Shoukry, N. H., Cawthon, A. G., and Walker, C. M. (2004) Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu. Rev. Microbiol. 58, 391–424.CrossRefPubMedGoogle Scholar
  5. 5.
    Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Wierenga, E. A., Santantonio, T., Jung, M. C., et al. (1995) Possible mechanism involving T lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006–1007.CrossRefPubMedGoogle Scholar
  6. 6.
    Thimme, R., Oldach, D., Chang, K. M., Steiger, C., Ray, S. C., and Chisari, F. V., (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395–1406.Google Scholar
  7. 7.
    Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., et al. (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence and disease. Proc. Natl. Acad. Sci. USA 99, 15661–15668.CrossRefPubMedGoogle Scholar
  8. 8.
    Wedemeyer, H., He, X. S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169, 3447–3458.PubMedGoogle Scholar
  9. 9.
    Rehermann, B. and Naoumov, N. V. (2007) Immunological techniques in viral hepatitis. J. Hepatol. 46, 508–520.CrossRefPubMedGoogle Scholar
  10. 10.
    Lauer, G. M., Barnes, E., Lucas, M., Tim, J., Ouchi, K., Kim, A. Y., et al. (2004) High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127, 924–936.CrossRefPubMedGoogle Scholar
  11. 11.
    Nascimbeni, M. and Rehermann, B. (2004) Determination of hepatitis B virus-specific CD8+ T-cell activity in the liver. Methods Mol. Med. 96, 65–83.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Joo Chun Yoon
    • 1
  • Barbara Rehermann
    • 1
  1. 1.Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney diseasesNational Institutes of HealthBethesdaUSA

Personalised recommendations